Saga Dx exit confirms SMA investment thesis - interview by Dagens Industri / Medtech & Digital Hälsa

Segulah Medical Acceleration was recently interviewed by Dagens Industri / Medtech & Digital Hälsa regarding Roche and Foundation Medicine’s acquisition of SAGA Diagnostics.

The transaction marks an important milestone for SAGA Diagnostics and further validates SMA’s investment thesis: backing innovative, research-driven companies developing technologies with the potential to transform diagnostics and patient care.

The full Dagens Industri article can be found here